Literature DB >> 28806270

New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding.

Neena S Abraham1.   

Abstract

PURPOSE OF REVIEW: To quantify antiplatelet-related gastrointestinal bleeding (GIB), characterize patients at greatest risk and summarize risk-management strategies emphasizing evolving knowledge in acute management of antiplatelet-related bleeding. RECENT
FINDINGS: New paradigms for acute management of antiplatelet-related GIB exist in the domains of resuscitation and the transfusion of blood products, strategic use of proton pump therapy and identification and eradication of Helicobacter pylori. This review will also highlight the importance of prompt resumption of cardiac aspirin and dual antiplatelet therapy following endoscopic hemostasis to minimize the risk of future cardiac events.
SUMMARY: This review will provide pragmatic strategies for the management of acute antiplatelet-related GIB. Emerging areas of clinical knowledge will be addressed and knowledge gaps requiring further research to inform clinical practice will be highlighted.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28806270     DOI: 10.1097/MOG.0000000000000394

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  2 in total

Review 1.  Antiplatelets, anticoagulants, and colonoscopic polypectomy.

Authors:  Neena S Abraham
Journal:  Gastrointest Endosc       Date:  2019-10-01       Impact factor: 9.427

Review 2.  Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life.

Authors:  Paolo Zappulla; Valeria Calvi
Journal:  TH Open       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.